Schmidt Erik Berg, Koenig Wolfgang, Khuseyinova Natalie, Christensen Jeppe Hagstrup
Department of Cardiology and Center for Cardiovascular Research, Aalborg Hospital, Århus University Hospitals, Sdr. Skovvej 15, 9100 Aalborg, Denmark.
Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany.
Atherosclerosis. 2008 Jan;196(1):420-424. doi: 10.1016/j.atherosclerosis.2006.11.027. Epub 2006 Dec 8.
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is an emerging risk factor for cardiovascular disease. In the present study, plasma levels of Lp-PLA(2) were measured in patients (n=301) admitted to elective coronary angiography because of suspected coronary artery disease (CAD). In a multiple linear regression analysis, the degree of CAD (0-, 1-, 2- or 3-vessel disease) and plasma LDL cholesterol significantly correlated to Lp-PLA(2) levels. Also the content of the marine n-3 fatty acid, eicosapentaenoic acid (EPA) in adipose tissue, a measure of long-term intake of seafood independently and inversely (r=-0.18, p<0.01) correlated with plasma levels of Lp-PLA(2). The results support the view that Lp-PLA(2) may relate to CAD and that intake of marine n-3 fatty acids might reduce plasma Lp-PLA(2) suggesting another mechanism by which n-3 fatty acids could reduce the risk of cardiovascular disease.
脂蛋白相关磷脂酶A2(Lp-PLA2)是一种新出现的心血管疾病风险因素。在本研究中,对因疑似冠状动脉疾病(CAD)而接受选择性冠状动脉造影的301例患者测定了血浆Lp-PLA2水平。在多元线性回归分析中,CAD的程度(0支、1支、2支或3支血管病变)和血浆低密度脂蛋白胆固醇与Lp-PLA2水平显著相关。此外,脂肪组织中海洋n-3脂肪酸二十碳五烯酸(EPA)的含量,作为长期海鲜摄入量的一个指标,与血浆Lp-PLA2水平呈独立负相关(r = -0.18,p<0.01)。这些结果支持以下观点:Lp-PLA2可能与CAD有关,而摄入海洋n-3脂肪酸可能会降低血浆Lp-PLA2水平,这提示了n-3脂肪酸降低心血管疾病风险的另一种机制。